Queensland University and University College London team on tackling epilepsy.
University College London (UCL) and Queensland University have entered into a collaborative agreement which aims to tackle epilespsy and pain treatment.
The two institutions will work together to identify and develop research projects, with support from their tech transfer units Uniquest and UCL Business.
Mark Ashton, UniQuest’s Executive Director, said: “We hope that through the collaboration and proof-of-concept funding provided by both parties we will be able to develop opportunities, mainly focussed on new therapeutics, that could attract translational funding to progress the projects towards the commercial stage where they would be partnered, with a larger share coming back to fund more university research and commercial opportunities.
“The reason for working with UCLB and UCL researchers is that UCL and UQ both have a similar approach to commercialisation with their respective commercialisation groups, UniQuest and UCLB being recognised as leaders in the space. Additionally, UCL are located in the UK where there are currently a number of opportunities for translational funding such as the Wellcome Trust. By partnering with UCL we hope to be able to access some of this also for the collaborative projects.”
